BCP
LRCX icon

BSN Capital Partners’s Lam Research LRCX Stock Holding History

BSN Capital Partners’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8M Buy
+133,172
New +$40.4M 2.25% 11

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BSN Capital Partners's LRCX Position: Q2 2026 in Review

BSN Capital Partners opened a new position in Lam Research (LRCX) in Q2 2026: 133,172 shares worth $49.8M. The stake represents 2.25% of the portfolio and ranks #11 among its holdings.

3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • BSN Capital Partners held 133,172 shares of Lam Research worth $49.8M as of Q2 2026.
  • Lam Research was a new BSN Capital Partners position in Q2 2026.
  • Lam Research made up 2.25% of BSN Capital Partners's portfolio in Q2 2026, its #11 holding.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on BSN Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.